Saif MW, Parikh R, Ray D, Kaye JA, Kurosky SK, Thomas K, Ramirez RA, Halfdanarson TR, Beveridge TJR, Mirakhur B, Nagar SP, Soares HP. Medical record review of transition to lanreotide following octreotide for neuroendocrine tumors. J Gastrointest Oncol. 2019 Aug;10(4):674-87. doi: 10.21037/jgo.2019.03.11
Galinksy J, Richard S, Morris M. Myeloma patients' self-reported experiences of care and treatment. Cancer Nurs Pract. 2016 Sep 14;15(7):22-6. doi: 10.7748/cnp.2016.e1341